But an association with improved overall survival failed to reach statistical significance ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to treat overactive bladder symptoms, reduces hot flashes compared to the ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

Drs Dean Ornish and Peter Carroll presented their research on the effects of an intensive lifestyle program on outcomes for ...

Francis Medical, Inc., a privately-held medical device company, announced the first commercial procedure using the Vanquish Water Vapor Ablation System at Pinnacle Surgery Center in Austin, Texas, by ...

Comprehensive website provides education, tools, and emotional support for those caring for loved ones with prostate cancer BUFFALO GROVE, Ill., Feb. 4, 2026 /PRNewswire/ -- Tolmar, Inc. today ...

“Oxybutynin demonstrated clear and clinically meaningful improvements in both hot flash frequency and quality of life for men undergoing hormone therapy for prostate cancer,” said lead researcher Dr.

AngioDynamics ANGO has been gaining from its solid prospects with NanoKnife and an increased focus on cancer treatment ...

What key experiences or clinical gaps motivated your focus on advancing prostate cancer diagnostics, particularly MRI-led ...

Chinese NMPA approves Bayer’s oral ARi Nubeqa in combo with ADT for use in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, February 4, 2026, 14:00 ...

Charlie Hoffman on building a $20bn client book – and never settling for less than the extra one per cent For Charlie Hoffman, winning awards is only part of the story. The HSBC Private Bank managing ...